Back to archive INCB 57643-103: A Phase 1, Open-Label, Safety and Tolerability Study of INCB057643 in Participants with Myelofibrosis Principal investigator: Minna Lehto HUS, Helsinki University Hospital, Comprehensive Cancer Center Link to the ClinicalTrials.gov study website
